The disease-causing hemorrhagic fever RNA viruses have the potential to be used as aerobiological weapons, indicating that accurate and timely identification of these agents is necessary. 1, 2 The implicated hemorrhagic fever viruses include Ebola, Marburg, Lassa, Junin, Machupo, Sabia, Guanarito, and hantavirus. TaqMan™-based, real-time reverse transcriptionpolymerase chain reaction (RT-PCR) can rapidly detect and identify the selected gene targets found within the genomes of these RNA viruses. Although many research groups have developed and tested standard and real-time RT-PCR assays for detection of various species and corresponding strains of Ebola, [3] [4] [5] [6] [7] [8] Marburg, 4, 8, 9 Lassa 8, 10-12 Junin, 13 and hantavirus, [14] [15] [16] [17] [18] a comprehensive panel of TaqMan™-based real-time PCR assays using identical cycling conditions is not currently available.
We designed 48 TaqMan™-based PCR assays for specific and absolute quantitative detection of multiple hemorrhagic fever viruses. A select few of these assays were used with unidentified human isolates drawn from suspected Lassa fever cases at the Kenema Government Hospital in Sierra Leone. The approved human use protocols for this study are United States Army Medical Research Institute of Infectious Diseases FY09-32 and Tulane University Institutional Review Board Study #09-00332.
Primer pairs and TaqMan™/TaqMan™-minor groove binder (MGB) probes were designed with either Primer Express version 2.0 (PE2) (Applied Biosystems, Foster City, CA; www .appliedbiosystems.com ) or AlleleID 4/5/6 (PREMIER BioSoft, Palo Alto, CA; www.premierbiosoft.com ) using gene targets and genomes identified by accession numbers in Table 1 . Hemorrhagic fever virus family genomes were initially aligned using ClustalW2 ( http://www.ebi.ac.uk/clustalw/index.html ) with nonhomologous regions identified visually. The PE2 software was then implemented to design virus-specific TaqMan™ and TaqMan™-MGB assays. Viral genomes aligned with AlleleID used the integrated ClustalW2 algorithms with the SpeciesSpecific Design option selected in the software. After primer/ probe targets were chosen by the software, corresponding viral genes were identified. Development of pan assays, defined as a single assay capable of detecting multiple viral sequences, were also attempted using the Taxa-Specific/Cross-Species Design option of AlleleID. AlleleID was able to design pan assays for detection of Marburg virus only ( Table 1 ) . The design of virus-specific assays by both software programs resulted in 48 primer/probe pairs (27 TaqMan™-MGB and 21 TaqMan™) using several gene targets: nucleoprotein, glycoprotein, virus protein 40, polymerase, and zinc-binding protein.
Virus preparations were produced in continuous cell lines appropriate for each virus. Virus stocks were harvested prior to peak cytopathic effects to minimize contaminating cellular components such as RNA or DNA. The cell culture supernatant containing intact virions was clarified by high-speed centrifugation. For extraction of viral RNA, virus stock was added to a virus-inactivating volume (3:1) of TRIzol reagent (Invitrogen, Grand Island, NY; www.invitrogen.com ). Four-hundred microliters of TRIzol-inactivated virus was either extracted manually using the Ambion MagMAX™ Viral RNA Isolation Kit (Ambion, Austin, TX; www.ambion.com ) or automated using the BioRobot EZ1 Virus Mini Kit V 2.0 (Qiagen, Valencia, CA; www.qiagen.com ). All viral genomic RNAs were eluted in 60 μL of elution buffer (Ambion) or AVE buffer (Qiagen) and stored at −80°C. In a related study, viral RNA extracted by the Qiagen and Ambion methods was directly compared using identical assay conditions and viral genomic RNA concentrations and resulted in uniform cycle threshold (C t ) regardless of extraction method. 19 All real-time RT-PCR assays were performed with specific primers and probes using the Invitrogen SuperScript™ Table 1 Real-time PCR assay primers, probes, reaction concentrations and sensitivities * (continued) Sensitivity testing using cell culture supernatant viral genomic RNA with a known plaque-forming units (PFU) concentration determined the LOD of each assay. The LOD is defined as the lowest concentration of target RNA detected three of three times. The Lassa Macenta RNA PFU concentration was unknown. Therefore, the RNA was serially diluted 10-fold and the LOD was determined to be the lowest dilution detected three of three times. Additionally, for several assays, single-stranded full-length target RNA sequences synthesized by Dharmacon (Lafayette, CO; www.dharmacon.com ), were used to determine the target copy number. A 10-fold serial dilution (1 pg-1 ag/PCR) was used to determine the LOD. The equivalent target copy number was calculated based on the molecular weight and length of the target sequence. Moreover, once the LOD was established, a standard curve could easily be used for an absolute quantitative real-time RT-PCR (qRT-PCR) analysis of unknown samples.
Although the viral hemorrhagic fever virus assays were designed using the Roche LightCycler 2.0, all assays should be easily transferable with minimal master mixture adjustments to most TaqMan™-compatible machines, including the Fast Real-Time PCR System (Applied Biosystems), the SmartCycler (Cepheid, Sunnyvale, CA; www.cepheid.com ) the R.A.P.I.D and JBAIDS (Idaho Technology, Salt Lake City, UT; www.idahotech.com ), the Mx QPCR (Stratagene, La Jolla, CA; www.stratagene.com ) and the iCycler (Bio-Rad, Hercules, CA; www.bio-rad.com ). Recent data indicated an easy transfer of both probe chemistries from one platform to another through similar assay performance, sensitivity, and specificity on three of these instruments. 20 In a pilot evaluation of the TaqMan™-MGB assay designed to detect Lassa Josiah genomic RNA, 39 blood samples from patients infected with Lassa virus in Sierra Leone 21, 22 were tested as part of the Lassa surveillance and treatment program based at Kenema Government Hospital. 23, 24 Five of these samples were serially collected from one patient (#G-104) on days 1, 2, 3, 8, and 15 after admission to the Lassa Fever Ward. Viral genomic RNA was extracted from TRIzol-treated samples as described above and tested with the six Lassa TaqMan™-MGB assays (Josiah, Weller, Macenta, Pinneo, Mobala, and Mozambique). The resulting data from the LightCycler 2.0 software determined that blood of the patient was positive for Lassa Josiah on days 1, 2, 3, and 8 but was not detectable on day 15 . An absolute quantification analysis of viral load indicates that 714, 633, 447 and 555 PFU/mL of patient blood were detected in samples on days 1, 2, 3 and 8, respectively. Of the remaining patient samples, 23 were positive for Lassa Josiah. Every Lassa Josiah-negative patient sample was also negative in the other five Lassa assays. All assays exhibited robust positive controls, and all negative controls were as expected. These results indicate that the six Lassa virus-specific TaqMan™-MGB assays were highly specific with the capability to detect potential clinically relevant levels of Lassa virus.
In conclusion, the assays presented in this report are highly specific and sensitive for detection of multiple hemorrhagic fever viruses. Rigorous design of primers and probes (length, melting point, amplicon size), stringent down selection, a strict optimization regiment, and common rapid-cycling parameters demonstrate that precise detection of multiple species/strains of filoviruses, arenaviruses, and New World hantaviruses (Sin Nombre and Andes viruses) is possible. Unknown samples can be tested simultaneously with multiple assays on TaqMan™-compatible instruments because these assays were designed, optimized, and validated by using identical cycling parameters. An additional benefit is the ability for researchers to multiplex the assays in any preferred combination.
Most importantly, because these are absolute qRT-PCR assays, researchers will be able to detect and identify unknown organisms in a sample and use the assays for viral load, vaccine, and antiviral drug studies. Additional validation of the assays with in-field samples will increase data on assay specificity and indicate their utility for clinical and environmental matrices. This collection of TaqMan™-based viral RNA real-time qRT-PCR assays provide a repertoire of diagnostic tools that can serve as a foundation for the simultaneous identification and analysis of these potential biothreat agents when multiple, rapid cycling, real-time PCR platforms are used.
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